Additionally, IF results showed the SDC1, as well as M2 macrophage biomarker CD206, were both of higher abundance in BC samples of high-risk patients, suggesting that SDC1 was indeed a tumor-promoting factor as previously reported and was positively linked to the expression of M2 macrophages (Figure 8B). This evidence concerns the gene MRC1 and breast cancer.